Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
4.070
+0.170 (4.36%)
At close: Oct 9, 2025, 4:00 PM EDT
4.030
-0.040 (-0.98%)
Pre-market: Oct 10, 2025, 8:13 AM EDT

Compass Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
-0.85----
Upgrade
Gross Profit
-0.85----
Upgrade
Selling, General & Admin
16.7315.1312.2411.6610.9312.91
Upgrade
Research & Development
51.1242.3438.123070.9614.9
Upgrade
Total Operating Expenses
67.8557.4850.3641.6681.8827.81
Upgrade
Operating Income
-67.85-56.63-50.36-41.66-81.88-27.81
Upgrade
Other Non-Operating Income (Expense)
5.827.257.872.43-0.3-1.66
Upgrade
Total Non-Operating Income (Expense)
5.827.257.872.43-0.3-1.66
Upgrade
Pretax Income
-62.03-49.38-42.49-39.23-82.18-29.47
Upgrade
Provision for Income Taxes
-----0.03
Upgrade
Net Income
-62.03-49.38-42.49-39.23-82.18-29.5
Upgrade
Net Income to Common
-62.03-49.38-42.49-39.23-82.18-29.5
Upgrade
Shares Outstanding (Basic)
1381371271056331
Upgrade
Shares Outstanding (Diluted)
1381371271056331
Upgrade
Shares Change (YoY)
4.28%8.15%20.76%67.31%104.28%515.52%
Upgrade
EPS (Basic)
-0.45-0.36-0.33-0.37-1.31-0.96
Upgrade
EPS (Diluted)
-0.45-0.36-0.33-0.37-1.31-0.96
Upgrade
Free Cash Flow
-45.25-44.9-40.65-34.34-21.23-26.91
Upgrade
Free Cash Flow Per Share
-0.33-0.33-0.32-0.33-0.34-0.87
Upgrade
Gross Margin
-100.00%----
Upgrade
Operating Margin
--6661.76%----
Upgrade
Profit Margin
--5808.82%----
Upgrade
FCF Margin
--5282.24%----
Upgrade
EBITDA
-66.29-54.87-48.47-39.75-80.26-25.41
Upgrade
EBITDA Margin
--6455.53%----
Upgrade
EBIT
-67.85-56.63-50.36-41.66-81.88-27.81
Upgrade
EBIT Margin
--6661.76%----
Upgrade
Effective Tax Rate
0.00%0.00%0.00%0.00%0.00%-0.11%
Upgrade
Updated Aug 11, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q